CSE: TRUE OTC: TREIF 939: FRA
CSE: TRUE OTC: TREIF 939: FRA

Treatment.com AI Funded by the National Institute of Health to Develop a Culturally Sensitive AI Approach to Health Equity

VANCOUVER, British Columbia, March 27, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce that the Company has received funding from The National Institute of Health (“NIH”) to develop a culturally sensitive AI approach for collecting family medical history. Treatment has partnered with Rush River […]

Treatment.com AI inc. Announces Debt Settlement Transactions

Vancouver, British Columbia, March 21, 2024 – Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) announces that it proposes to enter into debt settlement agreements with certain arms’ length creditors (the “Creditors”) to settle an aggregate of CAD$461,307.40 in debt (the “Debt”). The Debt relates to outstanding principal and accrued interest on […]

Treatment AI Passes Medical School Clinical Exam with 92% Success Rate

VANCOUVER, British Columbia, March 20, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce that it’s AI medical information support platform was used in the “Objective Structured Clinical Examination” (“OSCE”), a standard clinical exam of diagnostic aptitude at medical and nursing schools, passing the exam […]

Treatment.com AI Inc. Closes over-subscribed non-brokered private placement of $2,908,200

Vancouver, British Columbia, March 14, 2024 – Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce that, further to its news release dated February 16, 2024, it has closed a non-brokered private placement of 6,295,500 special warrants of the Company (each, a “Special Warrant”) at a price of $0.40 […]

Treatment.com AI Provides Corporate Update

Bolstering the Leadership Team The Global Library of Medicine Passes Milestone of 1000+ Diseases Treatment Provides Platform to Support Healthcare in Nairobi, Kenya VANCOUVER, British Columbia, February 29, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to provide a general corporate update. Treatment has been working […]

Treatment.Com International Inc. Announces Closing Of Non-Brokered Private Placement

Vancouver, British Columbia, October 5, 2023 – Treatment.com International Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce, further to its news release on September 28, 2023, the Company has completed its previously announced non-brokered private placement of common shares in the capital of the Company (each, a “Common Share”) at […]

Treatment.Com International Inc. Closes Non-Brokered Private Placement and Debt Settlement

Vancouver, British Columbia, September 29, 2023 – Treatment.com International Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce that further to its news release dated August 18, 2023, the Company has completed the previously announced non-brokered private placement of common shares in the capital of the Company (the “Common Shares”) at […]

Treatment.Com International Inc. Announces Non-Brokered Private Placement of Up To $500,000

Vancouver, British Columbia, September 28, 2023 – Treatment.com International Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce a non-brokered private placement of up to 3,333,333 common shares in the capital of the Company (each, a “Common Share”) at a price of $0.15 per Common Share (the “Offering”), for aggregate gross […]

Treatment.com International Inc. Announces Private Placement And Debt Settlement

Vancouver, British Columbia, August 18, 2023 – Treatment.com International Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce it has arranged a private placement of $1,000,000 issuable for 10,000,000 shares (the “Private Placement”). Additionally, the Company will settle up to $1,800,000 of Company liabilities at a price of $0.10 per share […]

Treatment Announces Convertible Debenture Private Placement

VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) — Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE; OTC: TREIF; FFA: 939), a global healthcare company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions, announces the proceeding of a non-brokered private placement, raising aggregate […]